Pharsight is a leading consultancy specializing in drug development analytics and payer strategies, serving biopharmaceutical companies. Operating in the healthcare and pharmaceutical markets, Pharsight combines real-world data analytics with proven payer strategies to optimize drug reimbursement and market access. The company’s core services include developing value strategies, positioning, and evidence synthesis across all stages of the reimbursement journey. Pharsight leverages its strong scientific background and understanding of public health challenges to provide effective market access and pricing solutions. The business model revolves around offering consultancy services and proprietary platforms like the D360 Scientific Informatics Platform and Certara Integral, which are used by thousands of scientists for drug discovery and data management. Pharsight generates revenue through consultancy fees and subscriptions to its data platforms.

Keywords: drug development, analytics, payer strategies, market access, reimbursement, biopharmaceutical, healthcare, data platforms, consultancy, scientific informatics.